^
Association details:
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
09/01/2021
Excerpt:
Cisplatin in combination with 5-FU/capecitabine, carboplatin or docetaxel-based combinations are alternatives in patients with ChT-naive advanced anal cancer [III, B].